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Objective: Excessive mechanical stress is considered a major cause of temporomandibular joint osteo-
arthritis (TMJ-OA). High magnitude cyclic tensile strain (CTS) up-regulates pro-inﬂammatory cytokines
and matrix metalloproteinases (MMPs) in chondrocytes, while selective cyclooxygenase (COX)-2 inhi-
bition has been shown to be beneﬁcial to cytokine-induced cartilage damage. However, the effect of
selective COX-2 inhibitors on mechanically stimulated chondrocytes remains unclear. This study evalu-
ated the effect of celecoxib, a selective COX-2 inhibitor, on extracellular matrix (ECM) metabolism of
mandibular condylar chondrocytes under CTS.
Methods: Porcine mandibular chondrocytes were subjected to CTS of 0.5 Hz, 10% elongation with cele-
coxib for 24 h. The gene expressions of COX-2, MMPs, aggrecanase (ADAMTS), type II collagen and
aggrecan were examined by real-time PCR. Also, prostaglandin E2 (PGE2) concentrations were deter-
mined using enzyme immunoassay kit. The levels of MMP and transcription factor NF-kB were measured
by western blot while MMP activity was determined by casein zymography.
Results: The presence of celecoxib normalized the release of PGE2 and diminished the CTS-induced COX-
2, MMP-1, MMP-3, MMP-9 and ADAMTS-5 gene expressions while recovered the downregulated type II
collagen and aggrecan gene expressions. Concurrently, celecoxib showed inhibition of NF-kB and sup-
pression of MMP production and activity.
Conclusions: Celecoxib exerts protective effects on mandibular condylar chondrocytes under CTS stim-
ulation by diminishing degradation and restoring synthesis of ECM.
 2014 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Temporomandibular joint osteoarthritis (TMJ-OA) is character-
ized by loss of the mandibular condylar cartilage, resulting in
painful and impaired occlusal function with limited jaw move-
ment1. Mechanical stress is considered to play an important role in
the damage of cartilage during OA. Optimal level of mechanical
loading is required for extracellular matrix (ECM) maintenance in
cartilage, whereas mechanical stress that exceeds physiological
tolerance could trigger the destruction of extracellular contents.o: K. Tanimoto, Department
roshima University Graduate
sumi, Minami-ku, Hiroshima
7-5687.
imoto).
lf of Osteoarthritis Research SocietECM of cartilage mostly contains collagen ﬁbers and proteoglycans.
The predominant proteoglycan in cartilage is aggrecan2. Collagens
and aggrecan can be directly cleaved by matrix metalloproteinases
(MMPs) and aggrecanases (ADAMTSs), both of which are key en-
zymes related to the degradation of ECM3. In previous studies, high
magnitude cyclic tensile load has been shown to induce the pro-
duction of MMPs in chondrocytes4,5. Nevertheless, the regulatory
mechanism was not fully elucidated.
Cyclooxygenase (COX) is an enzyme that converts arachidonic
acid to prostaglandins that have been implicated in causing pain
and bone resorption in TMJ6. Among the COX metabolites, prosta-
glandin E2 (PGE2) is considered one of the major mediators of
inﬂammation. It is reported that OA cartilage spontaneously re-
leases PGE2 at least 50-fold higher than normal cartilage7. The
therapeutic effect of non-steroidal anti-inﬂammatory drugs
(NSAIDs) ismainly attributed to their ability to inhibit COX activity8.y International.
Table I
The primer sequences for real-time RT-PCR
Gene Sequence 50-30
COX-2 Forward CTTACTGGAACATGGCATCAC
Reverse CTCTGCTCTGGTCGATTGA
MMP-1 Forward CTACACTTCGGGGAGAACTA
Reverse CGGACTTCATCTCTATCGG
MMP-3 Forward ACTGGATTTGCCAAGAAGTG
Reverse GCATAGGCATGAGCCAAAAC
MMP-9 Forward ACACACACGACATCTTCCAG
Reverse AGGTCACGTAGCCCACATAG
ADAMTS-4 Forward ACCTACCTGACTGGCACCATCAA
Reverse CATCTTGTCATCTGCCACCACCA
ADAMTS-5 (human) Forward CGCTGCCACCACACTCAA
Reverse CGTAGTGCTCCTCATGGTCATCT
COL2A1 Forward CCATCTGGCTTCCAGGGAC
Reverse CCACGAGGCCAGGAGCT
Aggrecan Forward TGCAGGTGACCATGGCC
Reverse CGGTAATGGAACACAACCCCT
GAPDH Forward TCATCCCTGCTTCTACCG
Reverse CAGATCCACAACCGACAC
S.-C. Su et al. / Osteoarthritis and Cartilage 22 (2014) 845e851846There are at least two isoforms of COX exist. COX-1 is expressed
constitutively for physiologic tissue homeostasis, while COX-2
expression is induced during inﬂammatory state9. Selective COX-
2 inhibitors have been demonstrated to have less side effects of
gastrointestinal irritation associated with non-selective COX in-
hibitors10. A few studies have shown that celecoxib, a selective
COX-2 inhibitor, could increase proteoglycan contents in both OA
cartilage explant and cytokine-stimulated healthy cartilage11,12. It
has been suggested that PGE2 derived from COX-2 modulates the
degradation of cartilage in human joint OA tissue stimulated with
pro-inﬂammatory cytokine13. However, the effect of COX-2Fig. 1. The effect of CTS on gene expressions and PGE2 level. Chondrocytes were subjected
at each time point were measured by real-time PCR (AeE). PGE2 concentration in supernatan
control group. Dotted lines represent the level at 0 h. Data are expressed as mean  SD, ninhibition on mechanically stimulated chondrocytes remains un-
clear. In this study, we examined the effect of celecoxib on ECM-
related molecule expressions with regard to COX-2 and PGE2
levels of mandibular condylar chondrocytes under cyclic tensile
strain (CTS).
Material and methods
Cell isolation and culture
Either side of themandiblewas obtained from two different pigs
in a local slaughter house for each experiment. Mandibular
condylar cartilage around the surface, approximately 1 mm of
depth, was carefully sliced into pieces and digested with 0.2%
Actinase E (Kaken) in a-minimum essential medium (Sigmae
Aldrich) for 1 h followed by 0.2% collagenase (Worthington) in the
medium for 3 h. Chondrocytes were ﬁltered and seeded at a density
of 2.5105 cells/well in 6-well BioFlex culture plates (Flexcell) pre-
coated with type I collagen. The culture was maintained in 2 ml of
medium supplemented with 10% fetal bovine serum (Biological
Industries) and 96 units/ml of penicillin (Meiji Seika) under an at-
mosphere of 5% CO2 in a humidiﬁed incubator at 37C. The medium
was changed every other day. After reaching conﬂuence, the me-
dium was gradually replaced with serum-free medium.
Application of CTS and treatment of NSAIDs
High magnitude CTS (0.5 Hz, 10% equibiaxial strain) was applied
using a Flexcell FX-2000 strain unit (Flexcell) with loading posts.
Chondrocytes without applying CTS were used as control. After 1, 3,
6, 12 and 24 h of stretching, the supernatant and the cells wereto CTS for 1, 3, 6, 12 and 24 h. Gene expressions of COX-2, MMP-1, -3, -9 and ADAMTS-5
t at each time point was measured by EIA kit (F).- represents CTS group,B represents
¼ 5. *: P < 0.05, **: P < 0.01 compared to controls at each time point.
Fig. 2. The effect of celecoxib and indomethacin on CTS-induced COX-2 expression
and PGE2 level. Chondrocytes treated with various concentrations of celecoxib and
indomethacin, were subjected to CTS for 24 h. Gene expressions were measured by
real-time PCR (A) and PGE2 level was measured by EIA kit (B). Data are expressed as
mean  95% conﬁdence intervals, n ¼ 3. **: P < 0.01 compared to CTS group.
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effect of selective COX-2 inhibition, cells treated with either cele-
coxib (Tocris; 0.1, 1, or 10 mM) or a non-selective COX inhibitor,
indomethacin (Wako; 0.1 or 10 mM), were subjected to CTS for 24 h.
Real-time RT-PCR analysis
Total RNA was extracted with TRIzol (Invitrogen) in accordance
with the manufacturer’s protocol. Reverse-transcription from total
RNA to cDNAwasmade using ReverTra Ace (Toyobo). Real-time PCR
was performed using SYBR Green PCR Master Mix (Toyobo) and
LightCycler system (Roche Diagnostics) to quantify target gene
expressions. The primer sequences are shown in Table I. No
appropriate sequence could be located for porcine ADAMTS-5,
therefore primers of human ADAMTS-5 were chosen14. Glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) was used as refer-
ence gene for comparison. Normalized cycle threshold (Ct) values
were compared relative to those of the controls. Data were calcu-
lated as relative expression by 2DCt, where the cycle threshold is
the beginning of logarithmic ampliﬁcation and DCt is the difference
of the target gene Ct subtracted from the reference gene Ct. Each
sample was analyzed in triplicate to ensure accuracy.
Measurement of PGE2 level
PGE2 in the collected medium was directly quantiﬁed using a
PGE2 EIA kit (Cayman). Data were interpreted into concentrations
according to the standard curve plot of each measurement.
Western blot analysis
Whole cell lysate was collected by adding Triton X-100 buffer
(Roche Diagnostics). Protein concentration was determined by
Bradford protein assay (Bio-Rad). Equal amounts (20 mg) of proteins
were run in each lane on a Tris-glycine gel using SDS-PAGE (Atto).
After electrophoresis, the proteins were transferred to poly-
vinylidene diﬂuoride (PVDF) membrane using i-Blot system (Invi-
trogen). The membrane was then blocked with 4% (w/v) Block Ace
(Yukijirushi) and probed with 1:1000 dilution of MMP-1 (Daiichi
Fine Chemical) or phospho-NF-kB (Cell Signaling Technology)
antibody overnight at 4C. Next, 1:2000 diluted horseradish
peroxidase conjugated anti-mouse antibody (Amersham) was used
as secondary antibody. Beta-actin was used to normalize the pro-
tein expressions. The signals were detected using Lightning Plus
ECL reagent (PerkinElmer) on radiographic ﬁlms.
Casein zymography
Supernatant media of the chondrocytes were collected after
being cultured with protease inhibitor for 48 h. Twenty-time
concentrated media were assayed for protease activity using
casein zymography. Equal amount of samples were separated in
non-reduced condition on a hand-cast 10% SDS-PAGE gel contain-
ing casein (Sigma). After electrophoresis, the gel was washed twice
with 2.5% Triton X-100 (Roche Diagnostics) in 50 mM TriseHCl for
30 min and incubated overnight at 37C in 50 mM TriseHCl with
5 mM CaCl2 and 50 mM ZnCl2. The gel was stained with 0.5% Coo-
massie Brilliant Blue R-250 and destained in 10% acetic acid until
clear bands appears. A commercial MMP marker (Cosmo Bio) was
loaded for identiﬁcation.
Statistical analysis
Each experiment was repeated at least three times. The gene
expression and PGE2 level at each time point were compared usingStudent’s t test. Homogeneity was checked and one-way analysis of
variance (ANOVA) with the TukeyeKramer post hoc test was used
to evaluate each gene expression of chondrocytes treated with
NSAIDs using SPSS software (IBM). Resulting P-value of less than
0.05was regarded as statistically signiﬁcant differencewhile that of
less than 0.01 was regarded as highly signiﬁcant difference.
Results
Effects of CTS on chondrocyte gene expressions and PGE2 level
It is well known that connective tissue cells adapt their ECM to
changes in mechanical load15. Compression and high ﬂuid shear
stress have been shown to induced COX-2 and matrix degrading
enzymes16,17. Our results revealed that COX-2, MMP-1 and
ADAMTS-5 gene expressions in mandibular condylar chondrocytes
became signiﬁcantly higher after 6 h of CTS application [Fig. 1(A),
Fig. 3. The effect of celecoxib and indomethacin on CTS-induced matrix degradative gene expressions. Chondrocytes treated with various concentrations of celecoxib and
indomethacin, were subjected to CTS for 24 h. Gene expressions of MMP-1, -3, -9 and ADAMTS-5 were measured by real-time PCR (AeD). Data are expressed as mean  95%
conﬁdence intervals, n ¼ 3. *: P < 0.05 **: P < 0.01 compared to CTS group.
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mRNA expressions were up-regulated from 12 h [Fig. 1(C): P¼ 0.01,
Fig. 1(D): P ¼ 0.005]. These expressions remained elevated after
24 h of CTS application. Consistent with the increase of COX-2
expression, PGE2 was signiﬁcantly enhanced after 6 h of CTS
application [Fig. 1(F): P ¼ 0.001]. The level of PGE2 became four
times greater than that of control after 24 h of CTS application
(P < 0.001). The data afﬁrmed the inducible nature of COX-2 and
the increased production of PGE2 upon pro-inﬂammatory stimuli.
Although the level of PGE2 detected in the supernatant was rela-
tively low compared to synovial ﬂuid in painful TMJ, we consider
the difference may be due to the monolayer culturing model used
in this study18.
Effect of celecoxib on CTS-induced gene expressions and PGE2 level
The treatment of celecoxib reduced the CTS-induced COX-2
gene expression in a dose-dependent manner while that of indo-
methacin failed to suppress COX-2 gene expression [Fig. 2(A):
P < 0.001]. Meanwhile, the enhancement of the PGE2 level by CTS
was abolished by all three concentrations of celecoxib and returned
to control level [Fig. 2(B): P < 0.001]. COX-2 selective inhibitors
are developed to reduce COX-2 activity by binding the enzyme.
However, the ﬁndings indicate that celecoxib also down-regulates
COX-2 expression in chondrocytes as is seen in other types of
cells19. Moreover, celecoxib exhibited inhibitory effects on CTS-
induced MMP-1 and ADAMTS-5 gene expressions at 0.1 mM
[Fig. 3(A): P < 0.001, D: P ¼ 0.002], while inhibited CTS-induced
MMP-3 and MMP-9 gene expressions at 1 mM [Fig. 3(B):
P ¼ 0.002, C: P ¼ 0.03]. The presence of celecoxib at 0.1 mM and1 mMwas also shown to diminish the adverse effect of CTS on type II
collagen and aggrecan gene expression, respectively [Fig. 4(A):
P ¼ 0.02, B: P < 0.001]. Except for MMP-9, indomethacin showed
same but lesser effect than celecoxib at same concentration. The
deﬁciency to inhibit MMP-3 and MMP-9 and restore aggrecan by
low concentration of celecoxib suggests that mechanical stimuli
might modulate these genes through other routes independent of
PGE2.
Effect of celecoxib on CTS-induced MMP production and activity
The unsecreted pro-form of MMP-1 in chondrocytes was up-
regulated by CTS as shown by western blot [Fig. 5(A)]. Pro-MMP-
1 production was slightly hindered by 0.1 mM of celecoxib and
further inhibited by higher concentrations. The supernatant was
analyzed for caseinolytic activity, indicative of MMP-3 as identiﬁed
by the marker [Fig. 5(B)]. A distinct band was visible in 48 h culture
medium of chondrocyte under CTS (Fig. 5, lane 3). The activity was
clearly hampered by the presence of 10 mMof Celecoxib (Fig. 5, lane
4). The expressions of the enzymes were consistent with the
changes in gene expressions.
Effect of celecoxib on phosphorylation of NF-kB
NF-kB is one of the crucial transcription factors in regulating
MMPs as well as aggrecanases expression in many types of cells20.
In this study, the phosphorylated NF-kB level was analyzed after 1 h
of CTS treated with celecoxib or indomethacin at 0.1 mM (Fig. 6). For
comparison, IL-1b (10 ng/ml) treated chondrocytes were used as
positive control. It is shown that CTS activated phosphorylation of
Fig. 4. The effect of celecoxib and indomethacin on CTS-induced matrix synthe-
sizing gene expressions. Chondrocytes treated with various concentrations of cele-
coxib and indomethacin, were subjected to CTS for 24 h. Gene expressions of type II
collagen and aggrecan were measured by real-time PCR (A, B). Data are expressed as
mean  95% conﬁdence intervals, n ¼ 3. *: P < 0.05 **: P < 0.01 compared to CTS group.
Fig. 5. The effect of celecoxib on pro-MMP-1 protein expression and caseinolytic
activity of MMP-3. Chondrocytes treated with various concentrations of celecoxib
were subjected to CTS for 24 h. Whole cell lysis was subjected to western blot analysis.
The bands of pro-MMP-1 and b-actin were shown (A). Chondrocytes treated with
10 mM of celecoxib were subjected to CTS for 48 h. Supernatant was collected and run
for zymography. The transparent areas were shown (B). The assays were representative
of three independent experiments with similar results.
Fig. 6. The effect of celecoxib and indomethacin on the phosphorylation of NF-kB.
Chondrocytes treated with 0.1 mM of celecoxib, indomethacin and IL-1b (10 ng/ml),
were subjected to CTS for 1 h. The blot was representative of three independent ex-
periments with similar results.
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activation (Fig. 6, lane 3). In contrast, phospho-NF-kB was not
affected by indomethacin (Fig. 6, lane 4).
Discussion
In TMJ, enhanced COX-2 expression is believed to be directly
related to joint pain and synovitis21. The COX-2 inhibitors pre-
scribed for temporomandibular joint inﬂammation elicit their ef-
fects by inhibiting COX activity22. There have been a few reports
regarding the effects of selective COX-2 inhibitors on arthritic
chondrocytes, including NS398 and celecoxib. Fermor et al. showed
that NS398 could block the compression-induced NO and PGE2
productions in articular cartilage23. Mastbergen et al. demonstrated
that celecoxib has a favorable effect on proteoglycan synthesis and
release of both preclinical degenerated and end-stage OA cartilage
slice cultures24. As demonstrated in this study, celecoxib exerted
same beneﬁcial effects with reduced level of PGE2 on chondrocytes
under excessive mechanical load. On the contrary, few reports
showed that continuous suppression of PGE2 accelerates the pro-
gression of OA25,26. It is thus implicated that PGE2 might have
both catabolic and anabolic properties. PGE2 is known to express its
effect through four EP receptors. High shear stress could induce apro-inﬂammatory cytokine through EP2 and EP3 receptors27,
whereas activation through EP4 inhibits MMP expressions in
chondrocytes28. However, the contribution of each EP receptor to
the pathogenesis of arthritis requires further investigation.
Besides indirect regulation through PGE2 pathway, it appears
that metabolism of ECM can be directly affected by mechanical
forces. A higher range of CTS magnitude may be pro-inﬂammatory,
while a lower magnitude may promote matrix synthesis in
meniscus cells29. It has been reported that CTS of different mag-
nitudes might regulate through the rapid nuclear translocation of
NF-kB in articular chondrocytes30. A recent report suggested cele-
coxib could inhibit IL-1b induced COX-2 and MMPs by suppressing
NF-kB and JNK31. Our ﬁndings are in accord with their result.
Analysis of the human COX-2 gene has revealed several regulatory
sites32. Different stimuli may regulate COX-2 expression by discrete
signaling pathways. High shear stress induces COX-2 expression
through a JNK2/c-jun dependent pathway in chondrocytes33. Me-
chanical stretch is reported to enhance COX-2 expression by acti-
vation of NF-kB in synovial cells34. Despite without investigating
detailed signaling event, we conﬁrmed the involvement of NF-kB
plays an important role in regulation of chondrocyte ECM meta-
bolism by mechanical stress35. On the contrary, indomethacin
failed to show such inhibiting effect, suggesting that celecoxib may
have property that is not shared by all NSAIDs36. The fact that
indomethacin also inhibits COX-1 might be involved as well. In a
S.-C. Su et al. / Osteoarthritis and Cartilage 22 (2014) 845e851850long term NSAID treatment in vivo study of knee, celecoxib
appeared to have different anti-inﬂammatory proﬁles than a non-
selective COX inhibitor in OA37.
In conclusion, this study demonstrated that celecoxib can
hinder MMPs and aggrecanase from digesting ECM and restore
matrix production by inhibiting COX-2, PGE2 and NF-kB. Overall, it
is suggested that celecoxib exerts protective effects on ECM meta-
bolism of mandibular condylar chondrocytes under excessive me-
chanical stress.
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